gdc
CLL Monthly Minutes

CLL Monthly Minutes

CLL Monthly MinutesLeukemia
The COVID-19 pandemic has resulted in several changes in how patients with chronic lymphocytic leukemia (CLL) are treated.
CLL Monthly MinutesLeukemia
Better identification of patients at high risk of disease progression and newer treatments may mean that fewer newly diagnosed patients must “watch and wait.”
CLL Monthly MinutesLeukemia
The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay.
CLL Monthly MinutesLeukemia
Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights.
CLL Monthly MinutesLeukemia
Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study.
CLL Monthly MinutesLeukemia
It is recommended that most patients with CLL receive the COVID-19 vaccine, although each patient should still talk with their healthcare team first.
CLL Monthly MinutesLeukemia
A new laboratory-based scoring system may allow physicians to better predict which patients with early-stage CLL are most likely to require early treatment.
CLL Monthly MinutesLeukemia
Patients with CLL may be at increased risk for developing severe COVID-19. Experts have provided insights on how to protect them while still delivering optimal care.
CLL Monthly MinutesLeukemia
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients.
CLL Monthly MinutesLeukemia
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know?
Page 1 of 3
Results 1 - 10 of 24

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country